RxDoctor Payments Data

Corey Wallach, MD

Orthopaedic Surgery of the Spine · Arlington, VANPI 1417923863

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $57,825 of the $76,503 with a category attached, or 75.6%. Medtronic accounts for 92.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $43,737 and has fallen 86.6% since, to $5,853 in 2025.

$76,503in general payments, 2019–2025

Across 257 payments — averaging $297.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$71K
  • HEMA Biologics, LLC$5K
  • Globus Medical$195
  • Stryker$100
  • Providence Medical Technology, Inc.$75
  • Centinel Spine, LLC$52
  • plus $173 from 6 others

What the payments were for

  • Consulting fees$4,8006%
  • Speaking & faculty fees$57,82576%
  • Travel & lodging$6,6739%
  • Food & beverage$7,2059%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,503 in reported general payments places this provider in the 75th percentile of 43 orthopaedic surgery of the spine providers in Virginia.

See all orthopaedic surgery of the spine providers in Virginia

Medicare billing

Part B allowed, 2024
$570,623
Medicare patients
792
Services billed
4,462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib139$2,722
Cyclobenzaprine Hcl124$596
Methylprednisolone21$206
Diclofenac Sodium18$175

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →